Articles related to BIPOLAR DISORDER

The new chemical entity is an atypical antipsychotic and the active metabolite of iloperidone (Fanapt). Its ability to cross the blood-brain barrier likely contributes to iloperidone’s clinical effects.

“Health care systems should recruit more trained psychologists and offer combinations of evidence-based pharmacotherapy and psychotherapy to patients with mood disorder, especially with suicide risk in resource-limited settings.” — Study authors, Journal of Psychiatric Research

Although not remarkably high, a 2.8% development of psychotic symptoms represents a nonnegligible figure and lends further meta-analytic support to the 2007 FDA change in the drug label for stimulants.

“Following a prescribed treatment plan can help people manage their symptoms and improve their quality of life.”

Studies show that bipolar disorder patients with severe symptoms demonstrate significant impairment in prospective memory – the ability to remember and execute planned future actions.

Lithium continues to be recognized as the most reliable mood stabilizer for bipolar disorder patients with a history of mania, necessitating precise management of dosages to prevent significant side effects.